← Ranking

AVGO · Broadcom Inc.

No alerts · No concrete new risks or important recent events

10-Q 2026-09-10 ↗ compared with the reference 10-K 10-K 2025-12-18 ↗

Closing price50-day average200-day average

Technical events and factor profile →

Summary

Broadcom warns of potential losses from AI customers reducing their business or canceling orders, and also faces risks from supply constraints, model spending priorities, and lease obligations.

Automatic summary generated from the filing; it may contain inaccuracies.
Concrete new risks
—
Generic new risks
—
Filing
10-Q · 2026-09-10

How the stock reacted

After the 10-Q1 session5 sessions20 sessions
AVGO-1.0%-6.8%+3.5%
Nasdaq-100 (QQQ)-1.1%-1.6%+5.9%
Difference+0.1%-5.2%-2.4%

From the close before the filing. Historical data, not a prediction.

Key figures quarterly · USD

Revenue (TTM)
$89.1B
YoY growth
+85.5%
Operating margin
53.9%
Cash / debt
$24.0B / $61.1B
Aug 26May 26Feb 26Nov 25Aug 25
Revenue$29.6B$22.2B$19.3B$18.0B$16.0B
YoY growth+85.5%+47.9%+29.5%+28.2%+22.0%
Gross margin69.1%69.5%68.1%68.0%67.1%
Operating margin53.9%48.6%44.3%41.7%36.9%
Net income$13.1B$9.3B$7.3B$8.5B$4.1B
Diluted EPS2.681.911.501.750.85

XBRL data filed with the SEC. The fourth fiscal quarter is calculated as the full year minus the previous three quarters.

Factor profile percentile vs. the S&P 500 and the Nasdaq-100

Momentum
12 months excl. last: -0.6% · 6 months -18.9%
36
Trend quality
R² 0.58 · falling
9
Relative strength
-29.0% vs. the S&P 500 over 6 months
10
Volatility
38% annualised
72
Beta
beta 2.12
92
Distance from high
-31.5% from the 52-week high
15
Extension
-2.4 standard deviations from its 20-day average
3

0 = the lowest in the universe, 100 = the highest. It describes how the stock has behaved, not whether to buy or sell it. Screen stocks by factors

Management tone MD&A

+9

Similar than in the previous 10-Q (2026-06-09: +11, -2 points)

10-Q of 2026-09-10 · 24.5% positive sentences, 13.3% negative · 143 sentences analysed

Index from −100 to +100 calculated with FinBERT on the results discussion (MD&A). The change matters more than the level: some sectors always sound more cautious.

Top funds 13F

Coatue Management · Philippe Laffont
held since Q1 2024
4.5% $2.2B +6%
Tiger Global · Chase Coleman
held since Q4 2023
2.8% $662.6M -51%
Bridgewater Associates · Ray Dalio
held since Q3 2023 or earlier
2.0% $497.8M -28%
Soros Fund Management · George Soros
held since Q4 2025
1.0% $62.4M +6%
ARK Investment Management · Cathie Wood
held since Q1 2026
1.0% $153.8M =
Appaloosa · David Tepper
held since Q2 2026
0.8% $56.7M new
Third Point · Dan Loeb — sold
Duquesne Family Office · Stanley Druckenmiller — sold

Weight in each fund's portfolio and change vs. the previous quarter, from its latest 13F.

Recent material events (8-K)

2026-09-02 Results releasedOther events 5 sessions: -1.7% vs Nasdaq-100 SEC ↗
2026-07-06 Other events 5 sessions: +9.2% vs Nasdaq-100 SEC ↗
2026-06-18 Other events 5 sessions: -2.7% vs Nasdaq-100 SEC ↗
2026-06-11 Other events 5 sessions: +1.4% vs Nasdaq-100 SEC ↗
2026-06-03 Results releasedOther events 5 sessions: -15.6% vs Nasdaq-100 SEC ↗

All material events for AVGO →

Insiders · last 90 days

Buys
—
Discretionary sells
—
10b5-1 plan sells
$250.0M
2026-09-23 SAMUELI HENRY · Director Sell (10b5-1 plan) $81.8M SEC ↗
2026-09-23 SAMUELI HENRY · Director Sell (10b5-1 plan) $66.3M SEC ↗
2026-09-23 SAMUELI HENRY · Director Sell (10b5-1 plan) $30.4M SEC ↗
2026-09-23 SAMUELI HENRY · Director Sell (10b5-1 plan) $18.2M SEC ↗
2026-09-23 SAMUELI HENRY · Director Sell (10b5-1 plan) $16.0M SEC ↗
2026-09-23 SAMUELI HENRY · Director Sell (10b5-1 plan) $8.2M SEC ↗
2026-09-23 SAMUELI HENRY · Director Sell (10b5-1 plan) $8.1M SEC ↗
2026-09-23 SAMUELI HENRY · Director Sell (10b5-1 plan) $8.0M SEC ↗
2026-09-23 SAMUELI HENRY · Director Sell (10b5-1 plan) $4.1M SEC ↗
2026-09-23 SAMUELI HENRY · Director Sell (10b5-1 plan) $3.6M SEC ↗
2026-09-23 SAMUELI HENRY · Director Sell (10b5-1 plan) $2.5M SEC ↗
2026-09-23 SAMUELI HENRY · Director Sell (10b5-1 plan) $1.6M SEC ↗
2026-09-23 SAMUELI HENRY · Director Sell (10b5-1 plan) $777K SEC ↗
2026-09-23 SAMUELI HENRY · Director Sell (10b5-1 plan) $185K SEC ↗
2026-09-23 SAMUELI HENRY · Director Sell (10b5-1 plan) $147K SEC ↗
2026-09-23 SAMUELI HENRY · Director Sell (10b5-1 plan) $143K SEC ↗

Source: SEC EDGAR. Automatic comparison of the risk factors section; it may contain extraction errors. Always check the original document. For information purposes only; not investment advice.